Canada's Natural Health Products (NHP) sector is facing a persistent challenge: the gap between policy intent and operational reality. Despite the federal government's stated priority of reducing red tape, recent updates indicate that meaningful burden reduction depends on the implementation of reforms to licensing, labeling, and system operations. While the government has signaled sector-specific changes, including potential reforms to product licensing pathways and labeling requirements, the industry is concerned that these measures may only provide modest relief if not designed as proper modernization efforts.
One of the key areas of focus is licensing. Proposed shifts towards streamlined or notification-based approaches for lower-risk products aim to reduce review timelines and administrative bottlenecks. However, these proposals must address long-standing industry concerns with delays, backlogs, and duplicative review processes. The industry is calling for licensing reforms that deliver meaningful reductions in both time and cost, not just review timelines.
Labeling is another critical area. The government has signaled openness to revisiting current requirements, which were originally complex and costly. Previous regulatory changes introduced significant redesign and compliance costs, particularly for small and medium-sized enterprises (SMEs) managing large product portfolios. The industry is calling for a true modernization of labeling that prioritizes flexibility, addressing formatting rigidity, update triggers, and alignment with international approaches.
However, early indications suggest that the proposed measures may deliver only modest relief if not designed as proper modernization efforts. Streamlined licensing pathways that retain the same underlying evidence, labeling, and post-market requirements will have limited impact on overall compliance costs. Similarly, labeling updates that do not address formatting rigidity, update triggers, and alignment with international approaches risk being perceived as additional red tape.
The sector continues to experience what is described as "hidden red tape," a burden driven not by regulation itself, but by how it is implemented by Health Canada. Companies report inconsistent interpretation of requirements, evolving and sometimes expanding evidence expectations, and a lack of predictability in the review process. Even when guidance documents and monographs exist, submissions are frequently subject to additional information requests, creating delays and increasing costs.
Recent updates to Good Manufacturing Practices (GMP), particularly through revised guidance, further illustrate this trend. While the regulatory framework has not fundamentally changed, expectations have shifted towards more formalized quality management systems, including enhanced requirements for risk management, corrective and preventive actions (CAPA), change control, and internal audits. These changes have increased documentation and compliance burden, disproportionately affecting SMEs due to significant increases in costs in a short time period.
Competitiveness pressures are intensifying, with a key concern being the uneven enforcement landscape, particularly in cross-border e-commerce. Canada's 90-day personal importation provision is increasingly used at a commercial scale, allowing foreign products to enter the market without meeting the same regulatory requirements as domestic products. This creates an uneven playing field, undermines compliant Canadian businesses, and raises broader questions about regulatory sovereignty and consumer protection.
To address these challenges, the industry is calling for a more targeted and outcomes-focused approach to red tape reduction. This includes licensing reforms that deliver meaningful reductions in both time and cost, a true modernization of labeling that prioritizes flexibility, greater consistency and transparency in evidence requirements and regulatory decision-making, operational improvements within Health Canada, and modernized enforcement approaches that address cross-border disparities and restore competitive balance.
Canada has an opportunity to reestablish itself as a global leader in the NHP sector. However, this will require moving beyond high-level commitments and ensuring that current reform initiatives translate into measurable, on-the-ground reductions in industry's burden. The industry is watching closely to ensure that any discussions on red tape deliver real flexibility rather than incremental adjustments that layer on new elements without clear benefits.
